FDA.reportPublic FDA data

olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa]

RxCUI
754506
RxNorm name
olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa]
Display name
olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa]
Full name
olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b418946a-1ab4-4d89-a012-d94fc361a3c4ZyPREXA ZYDIS 5 MG Disintegrating Oral Tablet [PSN] · olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa] [SBD] · Zyprexa 5 MG Disintegrating Oral Tablet [SY] · Zyprexa Zydis 5 MG Disintegrating Oral Tablet [SY]468These highlights do not include all the information needed to use ZYPREXA safely and effectively. See full prescribing information for ZYPREXA. ZYPREXA (olanzapine) Tablet for Oral use ZYPREXA ZYDIS (olanzapine) Tablet, Orally Disintegrating for Oral use ZYPREXA IntraMuscular (olanzapine) Injection, Powder, For Solution for Intramuscular use Initial U.S. Approval: 199620260211
d5051fbc-846b-4946-82df-341fb1216341ZyPREXA ZYDIS 5 MG Disintegrating Oral Tablet [PSN] · olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa] [SBD] · Zyprexa 5 MG Disintegrating Oral Tablet [SY] · Zyprexa Zydis 5 MG Disintegrating Oral Tablet [SY]467These highlights do not include all the information needed to use ZYPREXA safely and effectively. See full prescribing information for ZYPREXA. ZYPREXA (olanzapine) Tablet for Oral use ZYPREXA ZYDIS (olanzapine) Tablet, Orally Disintegrating for Oral use ZYPREXA IntraMuscular (olanzapine) Injection, Powder, For Solution for Intramuscular use Initial U.S. Approval: 199620251118